Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0617cdb3291de5393e6401be84ae88b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7661a7d6884afaa44d908744a0a115b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4fb056479dbbe7c81e240a0c0e90785 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e790d9c5b512c36132cc2f408107b188 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d64cbb284015104674305db8129780d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2eb8ebe3cac0f64bb4be585f04af9cd8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70596 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2008-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2d60d63f968cb0544c79d6084dc3abe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea49095259ea52b1cb85004fb57fa88f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6481cab1d4391c6a7f2d6490e2e95bf8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b28675b0684861b0f7ceeac1df4d659e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6107c212e8389631966667543711a9ec |
publicationDate |
2013-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8580255-B2 |
titleOfInvention |
Method for the treatment of rheumatoid arthritis using a TLR2 antagonistic antibody |
abstract |
The present invention provides compositions and methods for the treatment of autoimmune diseases, in particular rheumatoid arthritis. Compounds which function as antagonists of Toll-like Receptor 2 are shown to suppress the immune response which result in the onset and progression of autoimmune disease. In particular monoclonal antibodies which have a binding specificity to Toll-like receptor 2 are disclosed for use in methods for the treatment and/or prophylaxis of autoimmune disease. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11414455-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10793595-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10118942-B2 |
priorityDate |
2007-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |